Biomarkers at the cutting edge of medical research

Biomarkers at the cutting edge of medical research

Biomarkers at the cutting edge of medical research


Free Online Articles Directory




Why Submit Articles?
Top Authors
Top Articles
FAQ
ABAnswers

Publish Article

0 && $ .browser.msie ) {
var ie_version = parseInt($ .browser.version);
if(ie_version Login


Login via


Register
Hello
My Home
Sign Out

Email

Password


Remember me?
Lost Password?

Home Page > Health > Biomarkers at the cutting edge of medical research

Biomarkers at the cutting edge of medical research

Edit Article |

Posted: Oct 01, 2010 |Comments: 0
|



]]>

The world of medical research is a complicated one, where developments and breakthroughs can take years to come, and yet when they do, have the ability to change the face of modern medicine. Although it is the major events that make it onto the news, every day scientists and researchers across the world are doing their bit to advance knowledge and develop drugs and new products which will eventually make their way onto the shelves and be used by people in need.

A growing part of this process involves the use of biomarkers, which companies all over the world are using to help speed up and improve research processes. Research however costs money and unfortunately there is not an endless supply, even when it comes to research into diseases such as cancer which can be found in over 200 forms and is now deemed to affect more than one in three people living in the UK during their lifetime.

The time and cost that it takes to conduct research and develop drugs is why many companies have begun making the use of biomarkers an integral part of their research process. From drug development to clinical trials, biomarkers are having a profound impact on the world or medical research.

Time and money is needed to carry out research and some of the figures involved, when you are talking about the major pharmaceutical companies, is quite staggering. Small companies do not have the kind of money to throw around and this means efficiencies need to be found where possible. For example, everything possible needs to be done to avoid spending time developing a potential new drug only to find it is not suitable months down the line for one reason or another.

By using biomarkers, it can be possible to stop valuable money being wasted as they have the potential to let researchers know much earlier in the process whether a drug will not be suitable in certain situations. This can save a considerable amount of time and of course money, as further tests will not need to be carried out on that particular version. The world’s smaller laboratories run on very tight margins more often than not and so being able to save money where possible is extremely important. It also means extra funding is likely to be forthcoming from financial backers.

Find out about biomarker research and how the practice of using biomarkers in laboratories is increasing across the world.

Retrieved from “http://www.articlesbase.com/health-articles/biomarkers-at-the-cutting-edge-of-medical-research-3383844.html

(ArticlesBase SC #3383844)

Watch your traffic increase just by submitting articles with us, click here to get started.
Liked this article? Click here to publish it on your website or blog, it’s free and easy!

Ben Dafftie
About the Author:

]]>

Questions and Answers

Ask our experts your Health related questions here…

Ask

200 Characters left

If a small business advertises “a portion of every job goes to medical research”, do they have to specify a percentage?
What country seems to be on the most cutting edge of technology?
Im from califronia my husband lost his job and its hard to find one right now. they cut my hours to 31/2 our income is only 1,300 i got on medical and food is there a grant to help with credit debt

Rate this Article

1
2
3
4

8 Replies to “Biomarkers at the cutting edge of medical research”

  1. I'm a little surprised to see GLP/DPP-IV drugs being pushed earlier and earlier. While their pathway is definitely intriguing, they're still relying solely on short term A1c data. I was under the impression that there have not yet been any studies completed looking at hard endpoints (I know Merck's lining up to take Januvia into CV disease – they're either brave or they have some fascinating internal data). I still marvel at the TZD story where biomarkers displaced thinking about physiological endpoints. Too much predictive biochemistry and not enough measured physiology.

  2. I'm a latecomer to your lovely blog…what this is advertising is a single-edge razor and blade, rather than the double-edge style marketed by Gillette. Single edge blades are thicker, and the wedge-shape of the edge is more pronounced. The best-known examples of single-edge razors and blades are the Gem and the Schick Injector.
    Even today, among wetshaving aficianados, debates rage over the merits of one over the other. Single edge blades are still being made, although the last razor was probably made in the 1970s.

Leave a Reply